2 completed, 1 recruiting, 1 terminated. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 2, Recruiting 1, Terminated 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow Lymphoma, B Cell: new trials by email Literature Review of Lymphoma, B Cell trials Research Report on Lymphoma, B Cell
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies UB-VV400, Rapamycin (sirolimus) - Lymphoma, B Cell, Lymphoma Non-Hodgkin | Phase 1 / Phase 2 | Recruiting | Umoja Biopharma | 274 | 2026-11-01 | 2026-11-10 |
| DepoCyt for Active Lymphomatous or Leukemic Meningitis cytarabine liposome injection - Neoplastic Meningitis, Lymphoma, B Cell | Phase 2 | Terminated | Duke University | 4 | 2006-06-01 | 2013-06-17 |
| Phase II Trial of Combined Modality Treatment in Primary Central Nervous System Lymphoma high dose methotrexate, high dose cytarabine, radiotherapy - Lymphoma, B Cell | Phase 2 | Completed | International Extranodal Lymphoma Study Group (IELSG) | 79 | 2003-07-01 | 2015-03-30 |
| Phase II Study of Combined Modality Treatment in Primary Testicular Non-Hodgkin's Lymphoma rituximab, CHOP, intrathecal methotrexate - Lymphoma, B Cell | Phase 2 | Completed | International Extranodal Lymphoma Study Group (IELSG) | 64 | 2000-11-01 | 2009-07-22 |
Lymphoma, B-Cell (4) · Leukemia (1) · Lymphoma (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Non-Hodgkin (1) · Meningeal Carcinomatosis (1)
Hemic and Lymphatic Diseases (4) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Central Nervous System Neoplasms (1) · Hematologic Diseases (1) · Meningeal Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Nervous System Neoplasms (1)
Radiotherapy (2) · Cytarabine (1) · Methotrexate (1) · Rituximab (1) · Sirolimus (1)
International Extranodal Lymphoma Study Group (IELSG) (2) · Duke University (1) · Umoja Biopharma (1)
Switzerland (2) · United States (2)
Emanuele Zucca, MD (2) · Andreas Sarris, MD (1) · Andres JM Ferreri, MD (1) · David Rizzieri, MD (1) · Luke Walker, MD (1) · Mary Gospodarowicz, MD (1) · Michele Reni, MD (1) · Umberto Vitolo, MD (1)